TFB Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1965201 OVERLAND PARK, KS

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$315,597

-$19,587 QoQ

Shares Held

2,498

+3.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#1,621

of 2,266 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TFB Advisors LLC holds $3,025,209 across 5 Drug Manufacturers - General names. GILD ranks #5 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	816	$978,734
2	AMGN	Amgen Inc	2,335	$845,550
3	BIIB	Biogen Inc.	2,424	$523,729
4	MRK	Merck & Co., Inc.	2,814	$361,599
5	GILD	Gilead Sciences, Inc. This page	2,498	$315,597

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$315,597	2,498	+3.9%	Shares	Sole	2026-08-06
2026-03-31	$335,184	2,405	-13.8%	Shares	Sole	2026-04-20
2025-12-31	$342,567	2,791	-1.2%	Shares	Sole	2026-02-13
2025-09-30	$313,686	2,826	-35.1%	Shares	Sole	2025-11-04
2025-06-30	$483,060	4,357	+1.9%	Shares	Sole	2025-07-30
2025-03-31	$479,237	4,277	-3.7%	Shares	Sole	2025-05-14
2024-12-31	$410,215	4,441	-52.7%	Shares	Sole	2025-01-29
2024-09-30	$787,844	9,397	+1.2%	Shares	Sole	2024-10-31
2024-06-30	$636,769	9,281	-12.1%	Shares	Sole	2024-07-30
2024-03-31	$773,153	10,555	+50.3%	Shares	Sole	2024-05-03
2023-12-31	$568,771	7,021	-38.9%	Shares	Sole	2024-01-18
2023-06-30	$886,227	11,499	+138.8%	Shares	Sole	2023-07-18
2023-03-31	$399,500	4,815	+8.4%	Shares	Sole	2023-04-10
2022-12-31	$381,431	4,443	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.